Markers of sarcopenia quantified by computed tomography predict adverse long-term outcome in patients with resected oesophageal or gastro-oesophageal junction cancer

European Radiology

Volumn 26, Issue 5, 2016, Pages 1359-1367

  Tamandl, Dietmar ^a   Paireder, Matthias ^a   Asari, Reza ^a   Baltzer, Pascal A ^a   Schoppmann, Sebastian F ^a   Ba Ssalamah, Ahmed ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Body composition measurements; Computed tomography; Oesophageal cancer; Outcome analysis; Sarcopenia

Indexed keywords

MARKER;

ADULT; AGED; ARTICLE; BODY COMPOSITION; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; ESOPHAGUS CANCER; FAT FREE MASS; FEMALE; GASTROESOPHAGEAL CANCER; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MUSCLE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; SARCOPENIA; SKELETAL MUSCLE; STOMACH CANCER; DIAGNOSTIC IMAGING; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; ESOPHAGUS RESECTION; GASTROESOPHAGEAL JUNCTION; MIDDLE AGED; POSTOPERATIVE COMPLICATION; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; X-RAY COMPUTED TOMOGRAPHY;

AGED; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; ESOPHAGOGASTRIC JUNCTION; ESOPHAGUS; FEMALE; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SARCOPENIA; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84940706982     PISSN: 09387994     EISSN: 14321084     Source Type: Journal    
DOI: 10.1007/s00330-015-3963-1     Document Type: Article

References (30)

1. Castro C, Bosetti C, Malvezzi M et al (2014) Patterns and trends in esophageal cancer mortality and incidence in Europe (1980-2011) and predictions to 2015. Ann Oncol 25:283–290
2. Gonzalez L, Magno P, Ortiz AP et al (2013) Esophageal cancer incidence rates by histological type and overall: Puerto Rico versus the United States Surveillance, Epidemiology, and End Results population, 1992–2005. Cancer Epidemiol 37:5–10
3. Gronnier C, Trechot B, Duhamel A et al (2014) Impact of neoadjuvant chemoradiotherapy on postoperative outcomes after esophageal cancer resection: results of a European multicenter study. Ann Surg 260:764–771
4. Hoppo T, Jobe BA (2013) Personalizing therapy for esophageal cancer patients. Thorac Surg Clin 23:471–478
5. Wikman A, Johar A, Lagergren P (2014) Presence of symptom clusters in surgically treated patients with esophageal cancer: implications for survival. Cancer 120:286–293
6. Baumgartner RN, Koehler KM, Gallagher D et al (1998) Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 147:755–763
7. Cosqueric G, Sebag A, Ducolombier C, Thomas C, Piette F, Weill-Engerer S (2006) Sarcopenia is predictive of nosocomial infection in care of the elderly. Br J Nutr 96:895–901
8. Prado CM, Lieffers JR, McCargar LJ et al (2008) Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol 9:629–635
9. Fearon K, Strasser F, Anker SD et al (2011) Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 12:489–495
10. Balentine CJ, Enriquez J, Fisher W et al (2010) Intra-abdominal fat predicts survival in pancreatic cancer. J Gastrointest Surg 14:1832–1837
11. Voron T, Tselikas L, Pietrasz D et al (2014) Sarcopenia impacts on short- and long-term results of hepatectomy for hepatocellular carcinoma. Ann Surg. doi:10.1097/SLA.0000000000000743
12. Awad S, Tan BH, Cui H et al (2012) Marked changes in body composition following neoadjuvant chemotherapy for oesophagogastric cancer. Clin Nutr 31:74–77
13. Yip C, Goh V, Davies A et al (2014) Assessment of sarcopenia and changes in body composition after neoadjuvant chemotherapy and associations with clinical outcomes in oesophageal cancer. Eur Radiol 24:998–1005
14. Ida S, Watanabe M, Karashima R et al (2014) Changes in body composition secondary to neoadjuvant chemotherapy for advanced esophageal cancer are related to the occurrence of postoperative complications after esophagectomy. Ann Surg Oncol 21:3675–3679
15. Sheetz KH, Zhao L, Holcombe SA et al (2013) Decreased core muscle size is associated with worse patient survival following esophagectomy for cancer. Dis Esophagus 26:716–722
16. Ba-Ssalamah A, Matzek W, Baroud S et al (2011) Accuracy of hydro-multidetector row CT in the local T staging of oesophageal cancer compared to postoperative histopathological results. Eur Radiol 21:2326–2335
17. House MG, Fong Y, Arnaoutakis DJ et al (2008) Preoperative predictors for complications after pancreaticoduodenectomy: impact of BMI and body fat distribution. J Gastrointest Surg 12:270–278
18. Budczies J, Klauschen F, Sinn BV et al (2012) Cutoff Finder: a comprehensive and straightforward Web application enabling rapid biomarker cutoff optimization. PLoS One 7, e51862
19. Shen W, Punyanitya M, Wang Z et al (1985) (2004) Total body skeletal muscle and adipose tissue volumes: estimation from a single abdominal cross-sectional image. J Appl Physiol 97:2333–2338
20. Koo HK, Park JH, Park HK, Jung H, Lee SS (2014) Conflicting role of sarcopenia and obesity in male patients with chronic obstructive pulmonary disease: Korean National Health and Nutrition Examination Survey. PLoS One 9, e110448
21. Poggiogalle E, Migliaccio S, Lenzi A, Donini LM (2014) Treatment of body composition changes in obese and overweight older adults: insight into the phenotype of sarcopenic obesity. Endocrine 47:699–716
22. Anandavadivelan P, Brismar TB, Nilsson M, Johar AM, Martin L (2015) Sarcopenic obesity: A probable risk factor for dose limiting toxicity during neo-adjuvant chemotherapy in oesophageal cancer patients. Clin Nutr. doi:10.1016/j.clnu.2015.05.011
23. Yip C, Dinkel C, Mahajan A, Siddique M, Cook GJ, Goh V (2015) Imaging body composition in cancer patients: visceral obesity, sarcopenia and sarcopenic obesity may impact on clinical outcome. Insights Imaging. doi:10.1007/s13244-015-0414-0
24. Martin L, Birdsell L, Macdonald N et al (2013) Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol 31:1539–1547
25. Idoate F, Cadore EL, Casas-Herrero A et al (2015) Adipose tissue compartments, muscle mass, muscle fat infiltration, and coronary calcium in institutionalized frail nonagenarians. Eur Radiol 25:2163–2175
26. Di Sebastiano KM, Yang L, Zbuk K et al (2013) Accelerated muscle and adipose tissue loss may predict survival in pancreatic cancer patients: the relationship with diabetes and anaemia. Br J Nutr 109:302–312
27. Chang D, Joseph DJ, Ebert MA et al (2014) Effect of androgen deprivation therapy on muscle attenuation in men with prostate cancer. J Med Imaging Radiat Oncol 58:223–228
28. Hammarstedt L, Thilander-Klang A, Muth A, Wangberg B, Oden A, Hellstrom M (2013) Adrenal lesions: variability in attenuation over time, between scanners, and between observers. Acta Radiol 54:817–826
29. Llop-Talaveron JM, Farran-Teixidor L, Badia-Tahull MB et al (2014) Artificial nutritional support in cancer patients after esophagectomy: 11 years of experience. Nutr Cancer 66:1038–1046
30. Manba N, Koyama Y, Kosugi S et al (2014) Is early enteral nutrition initiated within 24 hours better for the postoperative course in esophageal cancer surgery? J Clin Med Res 6:53–58